Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 1, 2010, Pages 20-26

  Pajek, Jernej ^a   Kveder, Radoslav ^a   Guček, Andrej ^a   Škoberne, Andrej ^a   Bren, Andrej ^a   Bučar, Maja ^b   Černe, Darko ^b   Lukač Bajalo, Jana ^b  

^a University Medical Centre Ljubljana   (Slovakia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Apoptosis; Cell free DNA; Glucose degradation products; Peritoneal dialysis; Peritoneal membrane

Indexed keywords

CELL DNA; PERITONEAL DIALYSIS FLUID;

ADULT; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL DEATH; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL INDICATOR; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DNA DETERMINATION; EFFLUENT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

APOPTOSIS; ASCITIC FLUID; BICARBONATES; BIOLOGICAL MARKERS; BUFFERS; CELL-FREE SYSTEM; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; DNA; FEASIBILITY STUDIES; FEMALE; FLUOROMETRY; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; NECROSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 77149172036     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00717.x     Document Type: Article

References (26)

1. Williams JD, Craig KJ, Topley N et al. Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002 13 : 470 479.
2. Miyata T, Devuyst O, Kurokawa K, van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002 61 : 375 386.
3. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004 19 : 2208 2216.
4. Alscher DM, Biegger D, Mettang T, van der Kuip H, Kuhlmann U, Fritz P. Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids. Artif Organs 2003 27 : 1035 1040.
5. Catalan MP, Reyero A, Egido J, Ortiz A. Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 2001 12 : 2442 2449.
6. Cendoroglo M, Sundaram S, Groves C, Ucci AA, Jaber BL, Pereira BJ. Necrosis and apoptosis of polymorphonuclear cells exposed to peritoneal dialysis fluids in vitro. Kidney Int 1997 52 : 1626 1634.
7. Ortiz A, Catalán MP. Will modulation of cell death increase PD technique survival? Perit Dial Int 2004 24 : 105 114.
8. Jahr S, Hentze H, Englisch S et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001 61 : 1659 1665.
9. Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 2004 1022 : 232 238.
10. Holdenrieder S, Stieber P. Therapy control in oncology by circulating nucleosomes. Ann. NY Acad Sci 2004 1022 : 211 216.
11. Fournié GJ, Martres F, Pourrat JP, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993 39 : 215 221.
12. Rainer TH, Wong LK, Lam W et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin chem 2003 49 : 562 569.
13. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin invest 1990 86 : 69 74.
14. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000 46 : 319 323.
15. Zeerleder S, Zwart B, Wuillemin WA et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003 31 : 1947 1951.
16. Lai KN, Lai KB, Szeto CC et al. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis 1997 29 : 699 705.
17. Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000 20 : 516 523.
18. Senn S. Cross-over Trials in Clinical Research. Chichester : John Wiley & Sons Ltd, 1993.
19. Williams JD, Topley N, Craig KJ et al. Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004 66 : 408 418.
20. Amore A, Cappelli G, Cirina P et al. Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant 2003 18 : 677 688.
21. Pajek J, Kveder R, Bren A et al. Short-term effects of a new bicarbonate/lactate buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008 28 : 44 52.
22. Stroun M, Maurice P, Vasioukhin V et al. The Origin and Mechanism of Circulating DNA. Ann. NY Acad Sci 2000 906 : 161 168.
23. Lukač-Bajalo J, Černe D. Klinični pomen zunajcelične DNK. In : Kržišnik C, Battelino T, eds. Pediatrična Pulmologija, (Izbrana Poglavja iz Pediatrije, 17). Ljubljana : Univerza v Ljubljani, Medicinska Fakulteta, Katedra za Pediatrijo, 2005 65 84.
24. Holdenrieder S, Stieber P, Bodenmüller H et al. Circulating nucleosomes in serum. Ann N Y Acad Sci 2001 945 : 93 102.
25. Krediet RT. The physiology of peritoneal solute transport. In : Gokal R, Khanna R, Krediet RT, Nolph KD, eds. Textbook of Peritoneal Dialysis, 2nd edn. Dordrecht : Kluwer Academic Publishers, 2000 149.
26. Korabecna M, Opatrna S, Wirth J et al. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci 2008 1137 : 296 301.